Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enjoin is a private, physician-led healthcare services company focused on clinical documentation integrity, coding quality, risk adjustment, and mid-revenue-cycle optimization for hospitals and health systems. Founded in 1988, the company works with provider organizations to improve documentation accuracy, reimbursement integrity, quality metrics, and physician alignment. Its offerings span inpatient CDI, population health and risk adjustment solutions, workforce solutions, advisory services, and technology-enabled products. Enjoin also markets software tools including EnFORM+, an AI-enabled CDI support platform, and CDocT, a web-based documentation training and reference application. The company appears to be a healthcare services and health IT business rather than a biotech, pharma, or therapeutic developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enjoin.